Baxter International Inc. (BAX)
BAX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/0001628280-26-007733-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | BAX on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000010456 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $11.2B |
| Net income | -$957.0M |
| Operating income | -$308.0M |
| Net margin | -8.5% |
| Operating margin | -2.7% |
| Revenue growth | +5.7% |
| Cash | $2.0B |
| Total assets | $20.1B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-29 |
| Cash and burn | $2.0B cash; operating cash flow $410.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 517,348,188 (2026-10-22); 514,055,805 a year earlier; 507,323,509 three years earlier. | Cover page 2026-10-22 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-05-30 |
| Auditor | PricewaterhouseCoopers LLP, Chicago, Illinois, United States | PCAOB Form AP 2026-02-27 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $3.0B | $294.0M | $558.0M | $2.0B | $844.0M | $11.6B | 10-Q 2026-10-29 |
| Q2 2026 2026-06-30 | $3.0B | $126.0M | $285.0M | $2.1B | $844.0M | $11.5B | 10-Q 2026-07-30 |
| Q1 2026 2026-03-31 | $2.7B | -$15.0M | $213.0M | $2.0B | $842.0M | $11.3B | 10-Q 2026-04-30 |
| Q4 2025 2025-12-31 | $3.0B | -$1.1B | $584.0M | $2.0B | $9.4B | $11.2B | 10-K 2026-02-12 |
| Q3 2025 2025-09-30 | $2.8B | -$46.0M | $237.0M | $1.7B | $755.0M | $11.0B | 10-Q 2026-10-29 |
| Q2 2025 2025-06-30 | $2.8B | $91.0M | $217.0M | $1.7B | $8.0M | $10.9B | 10-Q 2026-07-30 |
| Q1 2025 2025-03-31 | $2.6B | $126.0M | -$193.0M | $2.3B | $662.0M | $10.8B | 10-Q 2026-04-30 |
| Q4 2024 2024-12-31 | $2.8B | -$512.0M | $488.0M | $1.8B | $15.3B | $10.6B | 10-K 2025-02-21 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2025-11-20 |
| Latest annual report | 10-K | 2026-02-12 |
| Latest quarterly / interim | 10-Q | 2026-10-29 |
| Latest current report | 8-K | 2026-10-29 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.1% |
| 1 month | +3.7% |
| 3 months | -4.6% |
| Year to date | +35.1% |
| 1 year | +38.0% |
| From 52-week high | -9.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PEN | Penumbra Inc. | $320.62 | -0.09% | $12.6B |
| GKOS | Glaukos Corporation | $244.88 | -0.34% | $14.5B |
| SOLV | Solventum Corporation | $88.65 | -0.48% | $15.0B |
| PODD | Insulet Corporation | $145.29 | -4.72% | $10.1B |
| GMED | Globus Medical Inc. | $70.50 | -2.27% | $9.3B |
| TFX | Teleflex Incorporated | $157.10 | +1.51% | $6.2B |
| WST | West Pharmaceutical Services Inc. | $417.80 | +0.33% | $29.1B |
| DXCM | DexCom Inc. | $81.61 | -2.06% | $30.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier